The GLP-1 Savings-Card Fine Print Nobody Reads Until It Costs Them

Every GLP-1 manufacturer runs a savings card, and every one of them leads with a number like "$25 a month." That number is real. It is also conditional on facts about you that the ad never mentions, and the gap between "the card says $25" and "I paid $650" is one of the most common expensive surprises in this whole category.

I read the current terms across the major cards. Here is what the fine print actually says.

The $25 price is for commercially insured patients only

The headline savings number — as low as $25 a month — assumes you have commercial (employer or marketplace) insurance that already covers the drug. The card is not paying your whole cost. It is buying down the copay your insurance left you with. That is why it can be so small: your plan pays the bulk, the card covers most of what's left.

If your commercial plan does not cover the drug, the same card usually still helps, but the number is different — a fixed dollar amount off a much larger cash price, not $25. And if you are on Medicare, Medicaid, or TRICARE, the card does not work at all. Federal anti-kickback law bars manufacturer copay assistance for anyone in a government program. This is the single most common reason a card "stops working" — the patient moved onto Medicare and the $25 vanished overnight.

So before the card means anything, sort yourself into one of three buckets: commercially insured with coverage (the $25 case), commercially insured without coverage (a dollars-off case), or government-insured (no card at all). The card's value is completely different in each.

I laid out the copay-card-versus-insurance interaction, with the specific traps, here.

The cards expire — and most of them expire on the same day

Almost every current GLP-1 savings card carries an expiration date of December 31, 2026. Not "when you stop needing it" — a hard calendar date. After it, unless the manufacturer reissues, the discount is gone and you are back to the underlying price.

This matters because people enroll once, see a low pharmacy price, and stop thinking about it. Then a January refill quietly rings up at the full amount and they assume the pharmacy made an error. It didn't. The card lapsed. Put the expiration date in your calendar the day you enroll, and check the manufacturer's page in December for a reissue.

One exception worth noting: not every product publishes a fixed expiry — where a manufacturer hasn't stated one, don't assume the December 31 date applies. Read the specific card's terms, not the category's.

The text-message shortcut is not always the savings card

Here is the trap that catches the most careful people. Manufacturers advertise a text-to-enroll shortcode — "Text [WORD] to [NUMBER]." It looks like the fast way to get the savings card. Sometimes it is. Often it isn't.

Read closely and you'll find the shortcodes split into two very different things:

• A savings sign-up — texting the code actually starts your enrollment in the discount card. On the Wegovy side, for example, the "SAVE" shortcode is genuinely the savings sign-up.
• A coaching or reminder program — the code enrolls you in a patient-support texting service (dose reminders, coaching, a starter kit), which is not the savings card. Several Novo Nordisk and Lilly shortcodes are this. Texting them and then waiting for a discount to appear leaves you enrolled in text messages and still paying full price.

The tell is in the words right next to the shortcode. If it says "savings" or "offer," it's likely the card. If it says "support," "coaching," "reminders," or "starter kit," it's the other program. When in doubt, enroll through the manufacturer's savings page directly rather than the text shortcut, so you know which one you signed up for.

The current, honestly-labeled breakdown of which card is which — including which shortcode enrolls you in the actual discount versus a coaching line — is kept here for Wegovy and Ozempic.

The maximum-benefit cap is the ceiling, not the floor

Cards advertise the lowest you might pay. They also carry a maximum they will contribute per fill and per year — and if your underlying cost is high enough, you hit that ceiling and pay the rest yourself.

This is where the "$25" and the reality separate most sharply. If your plan doesn't cover the drug and the cash price is, say, several hundred dollars, the card knocks off its capped amount and leaves you the remainder. The card did exactly what its terms said. The $25 headline simply never applied to your situation.

Read the "maximum savings of $X per fill" line. That number, not the headline, tells you your real floor when your coverage is weak.

A five-minute checklist before you trust any GLP-1 card

1. Which bucket am I in? Commercial-with-coverage, commercial-without, or government-insured. This decides whether the card helps a lot, a little, or not at all.
2. What's the expiration date? Usually December 31, 2026. Calendar it.
3. What's the maximum per fill and per year? That's your real floor if coverage is thin.
4. Is the text shortcode the savings card or a coaching program? Read the words next to it.
5. Did my insurance status change? Moving to Medicare kills the card by law, not by choice.

None of this makes savings cards a bad deal. Used in the right bucket, they are the single biggest lever a commercially insured patient has. But the card is written to be quoted at its best case, and the best case belongs to one specific patient. Find out whether that patient is you before you plan a budget around $25.

Card terms, expiration dates, and shortcode labels verified July 2026 against manufacturer pages; these change, so confirm on the official card before enrolling.